ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 05 Aug 2019
Last Applicant/ Owned by
4 Hume Street
DUBLIN 2
IE
Serial Number
86794740 filed on 21st Oct 2015
Registration Number
N/A
Correspondent Address
David M. Perry
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ARALEZ PHARMACEUTICALS
Pharmaceutical preparations and substances for the prevention and treatment of pain, inflammation, migraine, parasitic and infectious diseases; Pharmaceutical preparations and substances for the prevention and treatment of dermatological, oncological, musculoskeletal, cardiovascular, cerebrovascular, blood, urological, gastrointestinal, neurological, respiratory and immunologic system related dise Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and substances for the prevention and treatment of pain, inflammation, migraine, parasitic and infectious diseases; Pharmaceutical preparations and substances for the prevention and treatment of dermatological, oncological, musculoskeletal, cardiovascular, cerebrovascular, blood, urological, gastrointestinal, neurological, respiratory and immunologic system related diseases and disorders
Mark Details
Serial Number
No 86794740
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 149905-00100
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.17.09 -
Curved line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 05th Aug 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 05th Aug 2019 | ABANDONMENT - NO USE STATEMENT FILED |
| 12th Dec 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 10th Dec 2018 | EXTENSION 4 FILED |
| 10th Dec 2018 | EXTENSION 4 GRANTED |
| 10th Dec 2018 | TEAS EXTENSION RECEIVED |
| 21st Jun 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 19th Jun 2018 | EXTENSION 3 FILED |
| 19th Jun 2018 | EXTENSION 3 GRANTED |
| 19th Jun 2018 | TEAS EXTENSION RECEIVED |